X0508 4 2025-12-16 0001581760 Life360, Inc. LIF 0001932661 Synge James C/O LIFE360, INC. 1900 SOUTH NORFOLK STREET, SUITE 310 SAN MATEO CA 94403 true false Common Stock 2025-12-16 4 S 0 2448 63.63 D 1518 I Held by ICCA Labs, LLC Common Stock 2025-12-16 4 S 0 1518 64.49 D 0 I Held by ICCA Labs, LLC Common Stock 194754 D The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $63.36 to $64.33, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range. The Reporting Person has shared investment control over Carthona Capital FS Pty Ltd. ("Carthona Capital"). Carthona Capital is a member of ICCA Labs, LLC, an entity that held an aggregate of 8,219 shares of the Issuer's common stock prior to the sales reported herein. The number of shares held as reported herein represents Carthona Capital's proportionate ownership interest in ICCA Labs, LLC. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $64.36 to $64.57, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range. Includes common stock and the number of shares of common stock underlying Chess Depositary Interests ("CDIs") as converted on a 1:3 common stock to CDI ratio. The CDIs are traded on the Australian Securities Exchange (the "ASX") and are held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX. Includes 1,405 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting. /s/ Jay Sood, as Attorney-in-Fact 2025-12-18